Recently diagnosed with cancer? You may be eligible to make a difference.

The Newly Diagnosed Pan-Cancer Collection Study collects a simple blood sample from individuals who have recently been diagnosed with a solid tumor and have not yet started treatment. These samples help researchers better understand cancer, identify new biomarkers, and support the development of future diagnostic tools and treatments.

By participating, you can help advance cancer research and contribute to improving care for future patients.

Interested in learning more or participating?
Contact our research team today to see if you qualify.